We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
36.50 | 2.11% | 1,766.50 | 1,765.50 | 1,766.50 | 1,766.50 | 1,735.00 | 1,735.50 | 17,477,197 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.75 | 72.71B |
Date | Subject | Author | Discuss |
---|---|---|---|
19/8/2020 12:33 | What makes a difference from years ago, the use of using AI for predicting potential future drugs speeds things up, its smarter way to get things right, nearly all rns from Astra and GSK regarding potential drugs has been positive, a lot more than negative news. Lets hope we are first with Corona vaccine, then shares into a new trading range. | montyhedge | |
19/8/2020 12:23 | Good news, thanks spud .... ;0 | tradermichael | |
19/8/2020 12:11 | Glaxo Vaccinates First Participant In Meningitis ABCWY Trial SmithKline PLC on Wednesday said it has vaccinated the first participant in phase 3 clinical trials of its 5-in-1 meningitis vaccine... spud | spud | |
18/8/2020 18:01 | Still I would not mind investing 130m and then Curevac comes to market, GSK stake worth over 1 billion.Yes peanuts but every little helps. | montyhedge | |
18/8/2020 16:46 | Money hedge...whats gsk worth?....somewhere between 14.50 and 16.20. Perma trading range. You live in a dreamworld. Gsk market cap 65b, its interest in curevac minuscule. | porsche1945 | |
18/8/2020 16:40 | Money hedge...whats gsk worth?....somewhere between 14.50 and 16.20. Perma trading range. You live in a dreamworld. Gsk market cap 65b, its interest in curevac minuscule. | porsche1945 | |
18/8/2020 15:27 | Maybe tomorrow Ftse will go below 6000 . | abdullla | |
18/8/2020 14:41 | Curevac profit taking now, understandable. | montyhedge | |
18/8/2020 14:26 | GSK certainly backed a winner, Curevac pre-opening price 92 dollars what's GSK worth ? | montyhedge | |
18/8/2020 09:52 | Good to hold gsk and azn in any portfolio at the moment, imho | marcela9 | |
18/8/2020 09:46 | Topped up this morning at £15.45.GSK now makes up nearly half my portfolio as I sold some dead wood shares to pay for it . I have been in GSK for the last five years only 1% down on my average price but happy with the divis | cyfalafwr | |
18/8/2020 09:45 | GSK's flu jab FLUARIX QUADRIVALENT will have a larger take-up this year onwards ..... | tradermichael | |
18/8/2020 09:20 | The prize for first massive, it's going to be a yearly jab along with the flu jab I would imagine. Walmart in US saying flu jab 50% more demand this autumn.New highs in shareprice if GSK/Sanofi first. About 15 horses in the race, Astra must be favourite, GSK must be second favourite.Exciting times ahead. | montyhedge | |
18/8/2020 09:09 | England and Germany neck-and-neck in race to produce first vaccine Both products have completed successful phase one and two trials, with data suggesting they produced a 'robust' immune response- antibodies and T-cells-in volunteers after two doses. | geckotheglorious | |
18/8/2020 07:26 | Yes, Glaxo holds an 8.5 per cent stake in Curevac, according to filings, and the sharp rise in Curevac’s share price since its flotation means that the stake was worth about $1 billion yesterday. | tradermichael | |
18/8/2020 07:16 | What a bonus for GSK. | montyhedge | |
18/8/2020 06:26 | https://www.thetimes | ayl30 | |
17/8/2020 17:27 | I'd not take a Russian vaccine(rushed), or a Chinese one tbh. | geckotheglorious | |
17/8/2020 16:16 | Just on that note, would you take a Russian or Chinese vaccine, not me, I want a western one that's been through phase iii. | montyhedge | |
17/8/2020 16:14 | Yes back the horse you think, but GSK getting paid 5.2% for holding.Fair bet I would say. Whoever's wins the prize will be massive. | montyhedge | |
17/8/2020 15:56 | Monty, Personally I'm backing Pfizer, or whichever Chinese Pharma co is in the most advanced development stages. | geckotheglorious | |
17/8/2020 15:03 | This Coronavirus vaccine will be given every year along with flu vaccine I presume, the prize for the first will be massive.My horse I'm backing GSK, in my opinion over £20 a share, but if not first or no successful vaccine, ok collect 5.2% dividend, so not to bad. | montyhedge | |
17/8/2020 10:47 | U.S. health officials hope to avoid "twindemic" as flu season approaches U.S. health authorities, still grappling with COVID-19, are crossing their collective fingers that the upcoming flu season will be very mild. If not, the healthcare system could be severely tested in a "twindemic" scenario. The Centers for Disease Control and Prevention (CDC) has ordered an additional 9.3M doses, far beyond its usual purchase of 500K, for uninsured people. The concern is not confined to America. Global officials are pushing flu shots even before they are available in clinics and doctors' offices. Influenza shots are rarely broadly mandated in the U.S., but the University of California system has ordered its 230K employees and 280K students to get vaccinated by November 1. Last year's flu season was considered mild but the viral infection still struck 39M - 56M Americans requiring up to 740K hospitalizations. Deaths totaled 24K - 62K. Experts believe a record 98M flu shots will be given in the U.S. this year, up ~15% from last year. "My concern as well....as we head into the autumn,and then winter.." | geckotheglorious | |
17/8/2020 10:22 | GSK tracks Ftse mainly when it's going down. | abdullla | |
17/8/2020 09:37 | GtG, well they would say that wouldn’t they, as human beings seriously impacted by Covid 19, but they would also wish to be first with the best possible solution, and so would we as shareholders. I get my pension from GSK as well as being a shareholder so I wish for a rapid solution for this pandemic, but would prefer GSK to be that one company who provides the first and the best solution. | jadeticl3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions